User menu

Reproducibility of clinical events adjudications in a trial of venous thromboembolism prevention.

Bibliographic reference Girard, P ; Penaloza, Andrea ; Parent, F ; Gable, B ; Sanchez, O ; et. al. Reproducibility of clinical events adjudications in a trial of venous thromboembolism prevention.. In: Journal of Thrombosis and Haemostasis, Vol. 15, no.4, p. 662-669 (2017)
Permanent URL http://hdl.handle.net/2078.1/186352
  1. European Medicines Agency Guideline on data monitoring committees http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003635.pdf
  2. Food and Drug Administration Guidance for clinical trial sponsors. Establishment and Operation of Clinical Trial Data Monitoring Committees http://www.fda.gov/downloads/Regulatoryinformation/Guidances/ucm127073.pdf
  3. Dechartres Agnes, Boutron Isabelle, Roy Carine, Ravaud Philippe, Inadequate planning and reporting of adjudication committees in clinical trials: Recommendation proposal, 10.1016/j.jclinepi.2008.09.011
  4. Arnold Donald M., Lauzier Francois, Rabbat Christian, Zytaruk Nicole, Barlow Cash Bronwyn, Clarke France, Heels-Ansdell Diane, Guyatt Gordon, Walter Stephen D., Davies Andrew, Cook Deborah J., Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness, 10.1016/j.thromres.2012.12.005
  5. Mahaffey Kenneth W, Harrington Robert A, Akkerhuis Martijn, Kleiman Neal S, Berdan Lisa G, Crenshaw Brian S, Tardiff Barbara E, Granger Christopher B, DeJong Ingrid, Bhapkar Manju, Widimsky Petr, Corbalon Ramón, Lee Kerry L, Deckers Jaap W, Simoons Maarten L, Topol Eric J, Califf Robert M, 10.1186/cvm-2-4-187
  6. Petersen John L., Haque Ghazala, Hellkamp Anne S., Flaker Greg C., Mark Estes N.A., Marchlinski Francis E., McAnulty John H., Greenspon Arnold J., Marinchak Roger A., Lee Kerry L., Lamas Gervasio A., Mahaffey Kenneth W., Comparing classifications of death in the Mode Selection Trial: Agreement and disagreement among site investigators and a clinical events committee, 10.1016/j.cct.2006.02.002
  7. Stuck Anna K., Fuhrer Evelyn, Limacher Andreas, Méan Marie, Aujesky Drahomir, Adjudication-related processes are underreported and lack standardization in clinical trials of venous thromboembolism: a systematic review, 10.1016/j.jclinepi.2013.09.011
  8. Roy Pierre-Marie, Rachas Antoine, Meyer Guy, Le Gal Grégoire, Durieux Pierre, El Kouri Dominique, Honnart Didier, Schmidt Jeannot, Legall Catherine, Hausfater Pierre, Chrétien Jean-Marie, Mottier Dominique, , Multifaceted Intervention to Prevent Venous Thromboembolism in Patients Hospitalized for Acute Medical Illness: A Multicenter Cluster-Randomized Trial, 10.1371/journal.pone.0154832
  9. SCHULMAN S., KEARON C., , Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients : Definitions of major bleeding in clinical studies, 10.1111/j.1538-7836.2005.01204.x
  10. Lucena Joaquín, Rico Antonio, Vázquez Rafael, Marín Rocío, Martínez Carmen, Salguero Manuel, Miguel Luciana, Pulmonary embolism and sudden–unexpected death: Prospective study on 2477 forensic autopsies performed at the Institute of Legal Medicine in Seville, 10.1016/j.jflm.2008.08.015
  11. Prandoni Paolo, Lensing Anthonie W.A., Prins Martin H., Ciammaichella Maurizio, Perlati Marica, Mumoli Nicola, Bucherini Eugenio, Visonà Adriana, Bova Carlo, Imberti Davide, Campostrini Stefano, Barbar Sofia, Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope, 10.1056/nejmoa1602172
  12. Righini Marc, Van Es Josien, Den Exter Paul L., Roy Pierre-Marie, Verschuren Franck, Ghuysen Alexandre, Rutschmann Olivier T., Sanchez Olivier, Jaffrelot Morgan, Trinh-Duc Albert, Le Gall Catherine, Moustafa Farès, Principe Alessandra, Van Houten Anja A., Ten Wolde Marije, Douma Renée A., Hazelaar Germa, Erkens Petra M. G., Van Kralingen Klaas W., Grootenboers Marco J. J. H., Durian Marc F., Cheung Y. Whitney, Meyer Guy, Bounameaux Henri, Huisman Menno V., Kamphuisen Pieter W., Le Gal Grégoire, Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism : The ADJUST-PE Study, 10.1001/jama.2014.2135
  13. Cohen Alexander T., Spiro Theodore E., Büller Harry R., Haskell Lloyd, Hu Dayi, Hull Russell, Mebazaa Alexandre, Merli Geno, Schellong Sebastian, Spyropoulos Alex C., Tapson Victor, Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients, 10.1056/nejmoa1111096
  14. Agnelli G., Bergqvist D., Cohen A. T., Gallus A. S., Gent M., , Randomized clinical trial of postoperative fondaparinuxversus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery, 10.1002/bjs.5154
  15. Lee Agnes Y. Y., Kamphuisen Pieter W., Meyer Guy, Bauersachs Rupert, Janas Mette S., Jarner Mikala F., Khorana Alok A., Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer : A Randomized Clinical Trial, 10.1001/jama.2015.9243
  16. Prins Martin H, Lensing Anthonie WA, Bauersachs Rupert, van Bellen Bonno, Bounameaux Henri, Brighton Timothy A, Cohen Alexander T, Davidson Bruce L, Decousus Hervé, Raskob Gary E, Berkowitz Scott D, Wells Philip S, , Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies, 10.1186/1477-9560-11-21
  17. Fishman G. I., Chugh S. S., DiMarco J. P., Albert C. M., Anderson M. E., Bonow R. O., Buxton A. E., Chen P.-S., Estes M., Jouven X., Kwong R., Lathrop D. A., Mascette A. M., Nerbonne J. M., O'Rourke B., Page R. L., Roden D. M., Rosenbaum D. S., Sotoodehnia N., Trayanova N. A., Zheng Z.-J., Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop, 10.1161/circulationaha.110.976092
  18. Agnelli Giancarlo, George Daniel J., Kakkar Ajay K., Fisher William, Lassen Michael R., Mismetti Patrick, Mouret Patrick, Chaudhari Umesh, Lawson Francesca, Turpie Alexander G.G., Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer, 10.1056/nejmoa1108898
  19. , Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism, 10.1056/nejmoa1113572
  20. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism : The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the European Respiratory Society (ERS), 10.1093/eurheartj/ehu283